» Articles » PMID: 19759262

Contextual Extracellular Cues Promote Tumor Cell EMT and Metastasis by Regulating MiR-200 Family Expression

Overview
Journal Genes Dev
Specialty Molecular Biology
Date 2009 Sep 18
PMID 19759262
Citations 292
Authors
Affiliations
Soon will be listed here.
Abstract

Metastatic disease is a primary cause of cancer-related death, and factors governing tumor cell metastasis have not been fully elucidated. Here, we address this question by using tumor cell lines derived from mice that develop metastatic lung adenocarcinoma owing to expression of mutant K-ras and p53. Despite having widespread somatic genetic alterations, the metastasis-prone tumor cells retained a marked plasticity. They transited reversibly between epithelial and mesenchymal states, forming highly polarized epithelial spheres in three-dimensional culture that underwent epithelial-to-mesenchymal transition (EMT) following treatment with transforming growth factor-beta or injection into syngeneic mice. This transition was entirely dependent on the microRNA (miR)-200 family, which decreased during EMT. Forced expression of miR-200 abrogated the capacity of these tumor cells to undergo EMT, invade, and metastasize, and conferred transcriptional features of metastasis-incompetent tumor cells. We conclude that tumor cell metastasis is regulated by miR-200 expression, which changes in response to contextual extracellular cues.

Citing Articles

Multi-omics analysis to uncover the molecular basis of tumor budding in head and neck squamous cell carcinoma.

Ourailidis I, Stogbauer F, Zhou Y, Beck S, Romanovsky E, Eckert S NPJ Precis Oncol. 2025; 9(1):73.

PMID: 40082664 PMC: 11906922. DOI: 10.1038/s41698-025-00856-2.


RNA sensing induced by chromosome missegregation augments anti-tumor immunity.

Sasaki N, Homme M, Murayama T, Osaki T, Tenma T, An T Mol Cell. 2024; 85(4):770-786.e7.

PMID: 39706184 PMC: 11888943. DOI: 10.1016/j.molcel.2024.11.025.


Identification of TUBB3 as an immunotherapy target in lung cancer by genome wide in vivo CRISPR screening.

Zhao D, Deshpande R, Wu K, Tyagi A, Sharma S, Wu S Neoplasia. 2024; 60:101100.

PMID: 39671912 PMC: 11699798. DOI: 10.1016/j.neo.2024.101100.


Superior antitumor immune response achieved with proton over photon immunoradiotherapy is amplified by the nanoradioenhancer NBTXR3.

Hu Y, Paris S, Sahoo N, Wang Q, Wang Q, Barsoumian H J Nanobiotechnology. 2024; 22(1):597.

PMID: 39354474 PMC: 11445951. DOI: 10.1186/s12951-024-02855-0.


Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy.

He K, Puebla-Osorio N, Barsoumian H, Sezen D, Rafiq Z, Riad T J Exp Clin Cancer Res. 2024; 43(1):251.

PMID: 39218928 PMC: 11367833. DOI: 10.1186/s13046-024-03165-x.


References
1.
Peinado H, Olmeda D, Cano A . Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer. 2007; 7(6):415-28. DOI: 10.1038/nrc2131. View

2.
Zhou B, Peyton M, He B, Liu C, Girard L, Caudler E . Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. Cancer Cell. 2006; 10(1):39-50. PMC: 4451119. DOI: 10.1016/j.ccr.2006.05.024. View

3.
Bender Kim C, Jackson E, Woolfenden A, Lawrence S, Babar I, Vogel S . Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell. 2005; 121(6):823-35. DOI: 10.1016/j.cell.2005.03.032. View

4.
Gibbons D, Lin W, Creighton C, Zheng S, Berel D, Yang Y . Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma. PLoS One. 2009; 4(4):e5401. PMC: 2671160. DOI: 10.1371/journal.pone.0005401. View

5.
Hingorani S, Wang L, Multani A, Combs C, Deramaudt T, Hruban R . Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell. 2005; 7(5):469-83. DOI: 10.1016/j.ccr.2005.04.023. View